A detailed history of Black Rock Inc. transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,731,036 shares of ITOS stock, worth $29.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,731,036
Previous 4,114,820 9.33%
Holding current value
$29.3 Million
Previous $56.1 Million 1.35%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.33 - $18.09 $3.96 Million - $6.94 Million
-383,784 Reduced 9.33%
3,731,036 $55.4 Million
Q1 2024

May 10, 2024

SELL
$9.89 - $13.64 $1.45 Million - $2 Million
-146,925 Reduced 3.45%
4,114,820 $56.1 Million
Q4 2023

Feb 13, 2024

SELL
$8.57 - $11.06 $6.76 Million - $8.73 Million
-789,223 Reduced 15.63%
4,261,745 $46.7 Million
Q3 2023

Nov 13, 2023

BUY
$10.95 - $14.6 $4.06 Million - $5.41 Million
370,774 Added 7.92%
5,050,968 $55.3 Million
Q2 2023

Aug 11, 2023

BUY
$12.93 - $18.05 $2.8 Million - $3.91 Million
216,888 Added 4.86%
4,680,194 $62 Million
Q1 2023

May 12, 2023

SELL
$13.02 - $22.62 $209,817 - $364,521
-16,115 Reduced 0.36%
4,463,306 $60.7 Million
Q4 2022

Feb 13, 2023

BUY
$17.77 - $21.6 $2.88 Million - $3.5 Million
162,264 Added 3.76%
4,479,421 $87.5 Million
Q3 2022

Nov 14, 2022

BUY
$18.6 - $27.25 $11.1 Million - $16.2 Million
595,920 Added 16.01%
4,317,157 $82.2 Million
Q2 2022

Aug 12, 2022

BUY
$16.57 - $35.1 $6.46 Million - $13.7 Million
389,924 Added 11.7%
3,721,237 $76.7 Million
Q1 2022

May 12, 2022

BUY
$31.92 - $47.45 $54.8 Million - $81.5 Million
1,718,085 Added 106.5%
3,331,313 $107 Million
Q4 2021

Feb 10, 2022

BUY
$26.23 - $47.86 $1.44 Million - $2.63 Million
54,992 Added 3.53%
1,613,228 $75.1 Million
Q3 2021

Nov 09, 2021

BUY
$23.91 - $29.58 $992,217 - $1.23 Million
41,498 Added 2.74%
1,558,236 $42.1 Million
Q2 2021

Aug 11, 2021

BUY
$17.9 - $36.1 $27.1 Million - $54.8 Million
1,516,738 New
1,516,738 $38.9 Million

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $279M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.